Therapy-related acute myeloid leukemia following treatment for cancer in childhood: A population-based registry study.

Catherine A BrownDanny R YouldenJoanne F AitkenAndrew S Moore

Published in: Pediatric blood & cancer (2018)

Although rare, t-AML is an important potential late effect of childhood cancer therapy. Prognosis is generally poor, with HSCT offering some survival benefit.

Keyphrases

acute myeloid leukemia
cancer therapy
childhood cancer
allogeneic hematopoietic stem cell transplantation
papillary thyroid
early life
drug delivery
young adults
squamous cell
stem cells
squamous cell carcinoma
combination therapy
risk assessment
bone marrow
lymph node metastasis
climate change